PolyPhotonix

PolyPhotonix is a bio-photonic business based in the UK that has developed a home-based, non-invasive, monitored treatment for one of the principal causes of blindness in the western world, Diabetic Retinopathy and Diabetic Macular Oedema. The Noctura 400 Sleep Mask, offers a novel and innovative treatment for Diabetic patients with serious sight complications, and it will significantly change the patient experience and related costs when compared with current treatments. Noctura 400 is the first product launched by the company from a portfolio of bio-photonic medical devices that are under development by PolyPhotonix